UK company record
Ori Biotech
Cell & gene therapy manufacturing hardware
VerifiedCore UK
Snapshot
- UK location
- London · London
- Sector
- Deeptech / hardware
- Latest recorded round
- Series B
- Latest recorded amount
- $100m+
- Date
- 2022-01-01
Legal-identity layer
Verified identity.
- Selected legal name
- ORIBIOTECH LTD
- Company number
- 09757696
- Companies House status
- active
- Incorporated
- 2015-09-02
Investors
- Chimera Abu DhabiParticipant
- Novalis LifeSciencesLead
- Puhua CapitalParticipant
- Kindred CapitalParticipant
Current directors and active controllers
- ANDERSEN, HenrikCurrent director
- FOSTER, Jason CharlesCurrent director
- HAY, Jonathan RussellCurrent director
- HUNT, AnthonyCurrent director
- JACKSON, Andrea LiapisCurrent director
- JENKINS, Annalisa Mary, DrCurrent director
- MEISTER, Paul MatthewCurrent director
- BARGE, Alan John, Drdirector
- CLARE, Barrydirector
- KEDAR, Sharondirector
- MASON, Christopherdirector
- MASON, Christopher, Professordirector
- Mr Farlan Singh VeraitchFormer controller
- SOCHA, Pierre Robertdirector
- TRACEY, William Patrickdirector
- VERAITCH, Farlan Singhdirector
- WIESCHHAUS, Adam Josephdirector
Funding rows
- Series B$100m+ · 2022-01-01
- Series A$30M · 2020-10-14
- Seed$9.4M (£7M) · 2020-01-09
Sources
- https://oribiotech.com/press-releases/ori-biotech-raises-over-100-million-in-series-b-funding-to-launch-innovative-cell-and-gene-therapy-manufacturing-platform
- https://www.prnewswire.com/news-releases/ori-biotech-raises-30-million-in-series-a-financing-to-advance-innovation-in-cell-and-gene-therapy-manufacturing-301152246.html
- https://oribiotech.com/press-releases/ori-biotech-raises-30-million-in-series-a-financing-to-advance-innovation-in-cell-and-gene-therapy-manufacturing
- https://www.prnewswire.com/news-releases/ori-biotech-announces-a-9-4m-seed-round-to-advance-innovation-in-cell-and-gene-therapy-manufacturing-300983736.html